ONXX Financial Facts

Selling, general and administrative: 87.51M
Total operating expenses: 200.56M
See Full Income Statement

Additional paid-in capital: 1.88B
Convertible senior notes due 2016: 180.7M
See Full Balance Sheet

Onyx Pharmaceuticals Inc. (ONXX) Earnings

  |   Expand Research on ONXX
Next EPS Date N/A EPS Growth Rate +41.2% *Last Qtr.
Average EPS % Beat Rate +32.1% Revenue Growth Rate +110.5% *Last Qtr.
Average % Move 1-Wk after EPS +0.1% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
11/1/12 Q312 -$0.79-$0.90 +$0.11$89.51M$80.02M N/A Details
5/2/12 Q112 -$0.68-$0.55 -$0.13$72M$69.82M N/A Details
8/1/12 Q212 -$0.68-$0.66 -$0.02$72.7M$72.07M N/A Details
8/3/11 Q211 -$0.43-$0.13 -$0.30$67.96M$74.72M N/A Details
8/8/13 Q213 -$0.40-$0.42 +$0.02$153M$151.73M N/A Details
2/21/13 Q412 -$0.36-$0.75 +$0.39$127.9M$113.17M N/A Details
11/2/11 Q311 -$0.31-$0.19 -$0.12$75.04M$80.38M N/A Details
2/23/11 Q410 -$0.28-$0.02 -$0.26N/A$67.22M N/A Details